The CDK7 inhibitor THZ1 alters RNA polymerase dynamics at the 5' and 3' ends of genes

Shilpa Sampathi, Pankaj Acharya, Yue Zhao, Jing Wang, Kristy R. Stengel, Qi Liu, Michael R. Savona, Scott W. Hiebert

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


The t(8;21) is one of the most frequent chromosomal translocations associated with acute myeloid leukemia (AML). We found that t(8;21) AML were extremely sensitive to THZ1, which triggered apoptosis after only 4 h.We used precision nuclear run-on transcription sequencing (PROseq) to define the global effects of THZ1 and other CDK inhibitors on RNA polymerase II dynamics. Inhibition of CDK7 using THZ1 caused wide-spread loss of promoter-proximal paused RNA polymerase. This loss of 5' pausing was associated with accumulation of polymerases in the body of a large number of genes. However, there were modest effects on genes regulated by 'superenhancers'. At the 3' ends of genes, treatment with THZ1 suppressed RNA polymerase 'read through' at the end of the last exon, which resembled a phenotype associated with a mutant RNA polymerase with slower elongation rates. Consistent with this hypothesis, polyA site-sequencing (PolyA-seq) did not detect differences in poly A sites after THZ1 treatment. PROseq analysis after short treatments with THZ1 suggested that these 3' effects were due to altered CDK7 activity at the 5' end of long genes, and were likely to be due to slower rates of elongation.

Original languageEnglish (US)
Pages (from-to)3921-3936
Number of pages16
JournalNucleic acids research
Issue number8
StatePublished - May 7 2019
Externally publishedYes

ASJC Scopus subject areas

  • Genetics


Dive into the research topics of 'The CDK7 inhibitor THZ1 alters RNA polymerase dynamics at the 5' and 3' ends of genes'. Together they form a unique fingerprint.

Cite this